Patients with inflammatory bowel disease (IBD) who develop COVID-19 should stop taking thiopurines, methotrexate, tofacitinib, and biological therapies during the viral illness, according to the AGA.
from WebMD Health https://ift.tt/2XwHTat
Tuesday, 14 April 2020
IBD and COVID-19: Hold Certain Meds, AGA Advises
from WebMD Health https://ift.tt/2XwHTat
0 comments:
Post a Comment